the therapeutic success of biologics, it has become evident that targeting a single cytokine does not completely abrogate the pathology of rheumatologic disease for all patients. In addition, many of these agents lose efficacy over time owing to immunogenicity [3] and the intravenous or subcutaneous ...
Adverse drug reactions (ADRs) are harmful reactions, resulting from the intake of one or more drug(s) and pose significant public health issues. In the USA, ADRs affect >6% of hospitalized patients, with 0.3% being fatal incidences1. ADRs may occur due to prolonged administration of a drug...